The drug "Platyphylline hydrotartrate" is a myotropic antispasmodic having pronounced vasodilating, antispasmodic and sedative properties. The action of this agent is based on the inhibition of cholinergic systems responsible for the transmission of excitation from the parasympathetic nerves directly to the executive organs, as well as suppression of the vasomotor centers. In addition, the drug "Platyphylline hydrotartrate" effectively prevents internal secretion, lowers the tone of the gallbladder and smooth muscles of the digestive tract, has a moderate spasmolytic effect, reduces the frequency and amplitude of peristaltic contractions of the stomach, helps relax the smooth muscles of the urinary tract and uterus. Separately it is worth noting that the use of this miotropic agent allows for a short time to eliminate pain syndrome. Especially it should be emphasized that, using the antispasmodic drug "Platyphylline hydrotartrate", it must always be remembered that it is poisonous and is dispensed from pharmacies strictly according to the prescription of the treating doctor.
If we talk about the characteristics of the dosage form of the release, this vasodilating agent is produced in the form of tablets and in the form of 0.2% solution for injection. As an active ingredient, this is the extract of leaves of broad-leafed ragwort.
The myotropic drug "Platyphylline hydrotartrate" is prescribed, as a rule, for the therapy of patients suffering from duodenal ulcers or stomach, with renal, intestinal or hepatic colic. The list of medical indications also includes inflammatory diseases of the gallbladder and bile ducts. For the treatment of angina, the appointment of this vasodilator is similarly shown, and, of course, a prescription is required for its purchase. "Platyphylline hydrotartrate" is recommended for use with spasms of the brain vessels, and in the early stages of hypertension. The use of this agent is also indicated for the treatment of bronchial asthma. For diagnostic purposes, this drug is actively used in ophthalmic practice.
Use of the drug "Platifillin hydrotartrate" is strictly not recommended for persons with severe kidney and liver diseases, as well as for those who suffer from severe cardiovascular disorders. In addition, this drug is contraindicated in prostate adenoma and glaucoma.
As for the specific features of this vasodilator drug, everything is very individual here. So, for example, to stop acute pain in the stomach ulcer or colic, first use the drug "Platyphylline hydrotartrate" intramuscularly. In the subsequent it is taken orally two or three times a day for 0.5 - 1 tablet. In ophthalmic practice this miotropic agent, as a rule, is used exclusively as a 2% solution. In any case, in each specific situation, the treatment regimen is developed only by the attending physician on the basis of the results of the analyzes.